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Abstract [3H]nicotine has been used as a photoaffinity agonist
to identify amino acids within the Torpedo nicotinic acetylcholine
receptor (nAChR) Q-subunit that contributes to the structure of
the agonist binding site. UV irradiation (254 nm) of nAChR-rich
membranes equilibrated with [3H]nicotine results in covalent
incorporation into K- and Q-subunits that is inhibitable by
agonists and competitive antagonists, but not by non-competitive
antagonists (Middleton, R.E. and Cohen, J.B. (1991) Biochem-
istry 30, 6887^6897). To identify sites of specific incorporation,
SDS-PAGE and reversed-phase HPLC were used to isolate
proteolytic fragments of [3H]nicotine-labeled Q-subunit. Amino-
terminal sequence analysis identified QTrp-55 as the major site of
[3H]nicotine photoincorporation in Q-subunit. Thus QTrp-55 is the
first amino acid within a non-K-subunit to be identified by
affinity labeling in direct contact with a bound agonist.
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Key words: Nicotinic acetylcholine receptor; Ligand binding
domain; Photoa⁄nity labeling; Nicotine; Tryptophan
1. Introduction
The Torpedo nicotinic acetylcholine receptor (nAChR), a
multi-subunit protein consisting of four homologous subunits
arranged as a pentamer (K2LQN) around a central pore, is the
best characterized member of the ligand-gated ion channel
protein superfamily (for review see [1,2]). Although initial
studies indicated that the two acetylcholine binding sites
were contained within the K-subunits, more recent data estab-
lish that the sites are localized at the K-Q- and K-N-subunit
interfaces. A⁄nity labeling studies with agonists and compet-
itive antagonists identi¢ed amino acids within three distinct
regions of Torpedo K-subunit primary structure which contrib-
ute to the binding sites (KTyr-93, KTrp-149, and KTyr-190 to
KTyr-198), and mutational analyses have established their
contributions to agonist and competitive antagonist binding
(reviewed in [3]). For mouse muscle nAChRs, mutational
analyses have identi¢ed amino acids di¡ering between Q- and
N-subunits that account for the preferential binding of some
ligands at the K-Q or K-N site. With reference to the Q-subunit
numbering, amino acids 116, 117 and 161 determine selectivity
for metocurine and other small competitive antagonists [4],
while 34, 111, and 174 confer selectivity for the peptide antag-
onist K-conotoxin M1 [5]. Amino acids at Q34 and 172 are the
primary determinants of site selectivity for the agonist carba-
mylcholine, with some contribution from residues at 57 and
115 [6]. Additionally, the acidic side chain at positions Q174
and N180 contribute to agonist and antagonist binding a⁄nity
[7]. Based upon a⁄nity labeling of Torpedo nAChRs, QTrp-55
and NTrp-57 were identi¢ed as primary sites of photoincorpo-
ration of the competitive antagonist [3H]d-tubocurarine (dTC)
[8], with QTyr-111 and QTyr-117 identi¢ed as minor sites [9],
while NAsp-180 was identi¢ed by chemical cross-linking from
KCys-192 [10].
The agonist [3H]nicotine can be used as a photoa⁄nity
reagent, since UV irradiation of Torpedo nAChR-rich mem-
branes equilibrated with [3H]nicotine results in pharmacolog-
ically speci¢c covalent incorporation in K- and Q-subunits.
While the e⁄ciency of photoincorporation is low (6 1% of
bound nicotine), both the concentration dependence of incor-
poration as well as its inhibition by agonists and antagonists
establish that [3H]nicotine is incorporated within the agonist
binding site in the desensitized state of the nAChR [11]. With-
in K-subunit, the primary site of photoincorporation is KTyr-
198, with additional labeling at KTyr-190 and KCys-192 and
193 [11]. In this work, we identify the primary site of
[3H]nicotine photoincorporation in the Q-subunit as QTrp-55.
2. Materials and methods
2.1. [3H]nicotine photolabeling of nAChR-rich membranes
nAChR-rich membranes were isolated from the electric organs of
Torpedo californica (Marinus, Westchester, CA) as described [11].
Membranes were stored in 38% sucrose/0.02% NaN3 at 380‡C and
contained 1.3 to 1.4 nmol [3H]acetylcholine (ACh) sites per mg of
protein. For photolabeling, nAChR-rich membranes (V10 mg pro-
tein at 2 mg/ml) were equilibrated with 15 WM [3H]nicotine (30 Ci/
mmol, New England Nuclear) in 250 mM NaCl, 5 mM KCl, 3 mM
CaCl2, 2 mM MgCl2, and 5 mM NaPO4, pH 7.0 with 1 mM oxidized
glutathione (an aqueous scavenger) and 30 WM proadifen (a desensi-
tizing non-competitive antagonist). Carbamylcholine (carb, 300 WM)
was added to some samples to de¢ne agonist inhibitable photoincor-
poration. Equilibrated samples were irradiated at 254 nm for 5 min
and nAChR subunits were isolated by sodium dodecyl sulfate-poly-
acrylamide gel electrophoresis (SDS-PAGE) as described previously
[11].
2.2. Isolation of proteolytic digestion products of [3H]nicotine-labeled
Q-subunit
Isolated Q-subunit (70 Wg) was digested with 0.25 U of endoprotei-
nase Lys-C (Boehringer Mannheim) in 55^70 Wl of 0.1 M Tris, pH 8.8,
with 0.5 mM DTT, 0.5 mM EDTA, and 0.05% SDS at 25‡C for
4 weeks with an additional 0.1 U of enzyme added after 3 weeks.
Isolated Q-subunit (170 Wg) was digested with 1.2 Wg Staphylococcal
aureus glutamyl endopeptidase (V8-protease, ICN Biochemical) in
285 Wl 0.1 M Tris, pH 6.8, with 0.75 mM DTT, 0.75 mM EDTA,
and 2% SDS for 12 h at 25‡C. Endoproteinase Lys-C digests were
FEBS 19861 20-2-98
0014-5793/98/$19.00 ß 1998 Federation of European Biochemical Societies. All rights reserved.
PII S 0 0 1 4 - 5 7 9 3 ( 9 8 ) 0 0 0 9 3 - 3
*Corresponding author. Fax: +1 (617) 734-7557.
E-mail: jbcohen@warren.med.harvard.edu
1Present address: Merck Research Laboratories, Rahway, NJ 07065,
USA.
Abbreviations: nAChR, nicotinic acetylcholine receptor; dTC, d-
tubocurarine; ACh, acetylcholine; carb, carbamylcholine
FEBS 19861 FEBS Letters 423 (1998) 223^226
fractionated by SDS-PAGE using the tricine gel system (16.5% T/3%
C) of Schaºgger and von Jagow [12], and the resulting gel was treated
with Amplify (Amersham), dried, and exposed to x-ray ¢lm to de¢ne
3H distribution. The autoradiogram was used as a template to excise
3H bands which were diced and eluted as described [8]. V8-protease
digests were fractionated by reversed-phase high performance liquid
chromatography (HPLC) using a Vydac C4 (214TP54) column at
0.5 ml/min with 20% acetonitrile/0.1% tri£uoroacetic acid (TFA) as
aqueous solvent and 80% isobutanol/20% acetonitrile, 0.1% TFA as
organic solvent and system components as described previously [13].
HPLC fractions of interest were pooled, dried by vacuum centrifuga-
tion, and resuspended in 100 Wl of 10 mM NaPO4 bu¡er, pH 7.0 with
1 mM DTT, 1 mM EDTA, and 0.1% SDS. For deglycosylation,
samples (10 Wl) were adjusted to 20 Wl in 200 mM NaPO4, pH 7.0
with either 0.5% Lubrol-PX (Pierce) for N-glycanase (250 mU, Gen-
zyme) or 1% SDS for endoglycosidase H (5 mU, Sigma). Samples
were then incubated overnight at 25‡C.
2.3. Amino acid sequence analysis
Sequence analysis was performed on an Applied Biosystems Model
470A protein sequencer with an inline Model 120A PTH-amino acid
analyzer. Approximately 40% of each cycle was injected into the ana-
lyzer for amino acid identi¢cation and 60% (Fig. 1) or 40% (Fig. 2)
was collected for scintillation counting. The actual cpm and pmol
detected are reported. Samples for sequence analysis were loaded
onto tri£uoroacetic acid treated glass-¢ber ¢lters coated with 3 mg
Polybrene. Cycle yields for PTH-amino acids were estimated from
peak heights. Mass values from sequencing were ¢t (Sigma Plot, Jan-
del Corp.) to the equation Mx = IoRx where Mx is the amino acid
mass in cycle x, Io is the initial mass of the peptide in pmol, and R
is repetitive yield.
3. Results
For preparative [3H]nicotine photolabeling, nAChR-rich
membranes, equilibrated with [3H]nicotine, were irradiated
at 254 nm for 5 min. Parallel reactions were carried out in
the absence and presence of the agonist carbamylcholine to
de¢ne agonist inhibitable photoincorporation. nAChR sub-
units were isolated from labeled membranes by preparative
slab gel electrophoresis (3carb/+carb in 3H cpm/Wg: K-sub-
unit, 1390/135; L-subunit, 140/85; Q-subunit, 575/110; and N-
subunit, 170/75).
To identify the sites of speci¢c [3H]nicotine photoincorpo-
ration within Q-subunit, isolated Q-subunit was digested with
endoproteinase Lys-C, and the digest was fractionated by
SDS-PAGE. Based upon gel slice analysis (Fig. 1A), 65% of
the speci¢c 3H incorporation in Q-subunit was recovered in a
single band of V22 kDa. Material contained within this band
was eluted from the gel and characterized by amino-terminal
sequence analysis (Fig. 1B). Prominent release of 3H (350
cpm) was seen in cycle 9, release that resulted from speci¢c
photolabeling of the agonist site since sequence analysis of the
fragment isolated from nAChRs labeled in the presence of
carb resulted in a s 90% reduction of 3H release in that cycle.
Analysis of the released PTH-amino acids revealed the pres-
ence of three peptides. The primary sequence began at QGlu-
47 (31 pmol) with secondary sequences at QVal-273 (7 pmol)
and Arg-148 from the L-subunit of the Na/K ATPase (10
pmol), which is a known contaminant of Torpedo nAChR Q-
subunit isolated by SDS-PAGE [13,14]. The release of 3H in
cycle 9 would correspond to QTrp-55 in the primary sequence
(QGlu-47), i.e. the amino acid that is the primary site of photo-
incorporation of [3H]d-tubocurarine [8].
To determine whether QTrp-55 was the source of 3H release
in cycle 9 of Fig. 1, the site of incorporation was also mapped
by use of S. aureus V8-protease. Isolated [3H]nicotine-labeled
Q-subunit was digested overnight with S. aureus V8-protease,
and the digest was then fractionated by reversed-phase HPLC
(Fig. 2A and B). Two peaks of 3H were detected and the four
fractions spanning each peak were pooled, concentrated, and
sequenced. For peak I (V19% organic) prominent release of
3H (230 cpm) was detected in cycle 7 (Fig. 2C). This sample
contained Q-subunit fragments beginning at QVal-102 (39
pmol) and QAla-49 (7 pmol). Release in cycle 7 was consistent
with photoincorporation at QTrp-55 within the QAla-49 pep-
tide. For the material in peak II (V22% organic from Fig.
2B) no signi¢cant 3H release was detected in 24 cycles of Ed-
man degradation (i.e. 6 20 cpm above background). Two
sequences were present, one beginning at the Q-subunit ami-
no-terminus (QGlu-1, 3 pmol) and the other at QLeu-373 (4
pmol, data not shown). For the 3H-labeled Q-subunit fragment
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Fig. 1. Mapping of the primary site of [3H]nicotine incorporation in
Q-subunit by use of endoproteinase Lys-C. nAChR membranes (9
mg, 11 nmol ACh binding sites) were photolabeled with 15 WM
[3H]nicotine in the absence (3carb) or presence (+carb) of 300 WM
carbamylcholine, and labeled Q-subunits (575 cpm/Wg 3carb, 110
cpm/Wg +carb) were isolated by SDS-PAGE. Aliquots of Q-subunit
(70 Wg) were digested with endoproteinase Lys-C and subsequently
fractionated by tricine SDS-PAGE (see Section 2). Panel A: 3H dis-
tribution as determined by liquid scintillation counting of 5 mm gel
slices cut from individual lanes containing 5 Wg aliquots (b, 3carb,
a, +carb). The peak of 3H was centered at 22 kDa. Molecular
mass standards (kDa): glyceraldehyde-3-phosphate dehydrogenase
(36), carbonic anhydrase (30), soybean trypsin inhibitor (20), and
myoglobin fragments (14, 8, 6). Panel B: 3H release pro¢les when
the material eluted from that 22 kDa band was sequenced (b,
3carb, 6000 cpm loaded, 2250 cpm left on the ¢lter after 34 cycles
of Edman degradation; a, +carb, 2000 cpm loaded, 500 cpm left
on the ¢lter after 16 cycles of Edman degradation). For the 3carb
sample three peptides were present, beginning at QGlu-47 (E,
I = 31 þ 3 pmol, R = 88 þ 1%), QVal-273 (I = 7 þ 1 pmol, R = 89 þ 1%),
and Na/K ATPase L-subunit Arg-147 (I = 10 þ 1 pmol,
R = 85 þ 2%). The dotted line represents a non-linear best ¢t of the
mass values from the QGlu-47 peptide as described in Section 2. The
+carb sample contained QGlu-47 (I = 9 þ 2 pmol, R = 90 þ 3%), QVal-
273 (I = 5 þ 1 pmol, R = 88 þ 1%), and Na/K ATPase L-subunit
Arg-147 (I = 5 þ 1 pmol, R = 85 þ 5%). Release of 3H in cycle 9 (350
cpm) was consistent with [3H]nicotine incorporation into QTrp-55
from the peptide beginning at QGlu-47. Calculated incorporation for
QTrp-55 was 24 cpm/pmol.
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in peak II, the site of 3H incorporation was characterized
relative to the known sites of glycosylation within Q-subunit.
Torpedo nAChR Q-subunit contains two sites of N-linked gly-
cosylation, Asn-68 and Asn-141 [8,15]. Both can be deglyco-
sylated by N-glycanase, which removes all N-linked carbohy-
drates [16], while Asn-68 is resistant and Asn-141 is sensitive
to endoglycosidase H, which removes high-mannose and some
hybrid N-linked carbohydrates [17]. Aliquots from peak II
were treated with endoglycosidase H or N-glycanase and an-
alyzed by tricine SDS-PAGE (Fig. 3). The untreated sample
(Fig. 3A) had a relative molecular mass of 17 kDa, and this
was not altered by treatment with endoglycosidase H (Fig.
3B), while deglycosylation with N-glycanase (Fig. 3C) resulted
in a 3H band of V8 kDa. Thus the 3H within peak II was
associated with the carbohydrate at QAsn-68, consistent with
3H incorporation at QTrp-55 in the fragment beginning at
QGlu-1.
4. Discussion
The primary site of photoincorporation of [3H]nicotine
within the Q-subunit of the Torpedo nAChR was identi¢ed
as QTrp-55 by sequence analysis of peptides isolated after sub-
unit digestion by endoproteinase Lys-C, which cleaves after
lysines, and by V8-protease, which cleaves after glutamic
acids. The calculated incorporation in QTrp-55 (24 cpm/
pmol, Fig. 1) was similar to the calculated speci¢c incorpora-
tion in the Q-subunit (460 cpm/Wg or 26 cpm/pmol). It is note-
worthy that QTrp-55 is also the principle site of photoincorpo-
ration in Q-subunit of the competitive antagonist [3H]d-
tubocurarine [8]. Within K-subunit the principle sites of pho-
toincorporation for both drugs are within the K190^198, but
[3H]nicotine reacts primarily with KTyr-198 while [3H]d-tubo-
curarine reacts primarily with KTyr-190 [8,11].
With our lack of knowledge of the precise photochemistry
of [3H]nicotine, it is not possible to determine the orientation
of nicotine within the agonist binding site, but it is likely that
both KTyr-198 and QTrp-55 interact with the same part of the
nicotine molecule that is photoactivated, which could be ei-
ther the aromatic (pyridine) or aliphatic (pyrolidine) nitrogen.
While it is possible that there are additional sites in Q-subunit
where [3H]nicotine is photoincorporated at much lower e⁄-
ciency than in QTrp-55, prominent photoincorporation was
not seen at QTyr-111 or 117, which contribute to antagonist
binding [4,5]. When a gel band containing a fragment begin-
ning at QVal-102 was sequenced (Fig. 2C), the observed 3H
release at cycles 10 and 16, corresponding to QTyr-111 and
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Fig. 3. Glycosidase sensitivity of [3H]nicotine-labeled Q-subunit frag-
ment produced by V8-protease. Aliquots (10 Wl, b, 3carb; a,
+carb) of material from HPLC peak II of Fig. 2B were treated as
described in Section 2 either without glycosidase (A), with endoglyc-
osidase H (B) or with N-glycanase (C). The digests were then frac-
tionated by tricine SDS-PAGE (10% T/3% C) and the 3H distribu-
tion was determined by liquid scintillation counting of the gel lanes
cut into 3 mm slices. The apparent molecular mass of the 3H con-
taining bands were 17 kDa for A and B and 8 kDa for C. Migra-
tion distances of molecular mass markers (kDa) are indicated for
carbonic anhydrase (30), L-lactoglobulin (19), lysozyme (16), and
bovine trypsin inhibitor (6). Only a portion of the gel is shown. The
remainder of the gel lanes contained no slices s 55 cpm.
Fig. 2. Identi¢cation of sites of [3H]nicotine incorporation in Q-sub-
unit by use of S. aureus V8-protease. Aliquots of Q-subunit (170 Wg,
3carb, 730 cpm/Wg; +carb, 144 cpm/Wg) were digested with V8-pro-
tease and then fractionated by reversed-phase HPLC. Panel A: ab-
sorbance at 280 nm; panel B: 3H elution pro¢les with 25 Wl ali-
quots of each 500 Wl fraction counted (b, 3carb, 122 000 cpm
injected, 100% recovered; a, +carb, 24 000 cpm injected, 91% recov-
ered). The dotted line represents the % organic. Four fractions were
pooled from peak I (20 300 cpm) and from peak II (42 700 cpm).
Panel C: 3H release pro¢le during sequence analysis of material
from peak I (b, 2900 cpm loaded, 1030 cpm left after 25 cycles of
Edman degradation). Two Q-subunit sequences were present begin-
ning at Val-102 (I = 39 þ 3 pmol, R = 90 þ 1%) and Ala-49 (E,
I = 7 þ 1 pmol, R = 88 þ 3%). The dotted line represents a non-linear
best ¢t of the mass values from the QGlu-47 peptide as described in
Section 2. Release of 3H in cycle 7 (224 cpm) was consistent with
incorporation at QTrp-55 from the Ala-49 peptide, with a calculated
incorporation of 78 cpm/pmol. Sequence analysis of material from
peak II in panel B revealed fragments beginning at QGlu-1
(I = 3.4 þ 0.4 pmol, R = 94 þ 1%) and QLeu-373 (I = 4.5 þ 0.5 pmol,
R = 93 þ 1%). Release of 3H was 6 20 cpm (2800 cpm loaded and
2000 cpm left after 24 cycles of Edman degradation).
D.C. Chiara et al./FEBS Letters 423 (1998) 223^226 225
QTyr-117, establishes that any 3H incorporation would be at
6 5% the e⁄ciency of QTrp-55. Since there are no aromatic
side chains in the primary structure near QLys-34, another
agonist binding determinant, [3H]nicotine probably could
not photoincorporate into that region even if in proximity,
while QTrp-170 is proximal to other agonist a⁄nity determi-
nants (Q172/174) [6,7] without evidence for [3H]nicotine photo-
incorporation in that region.
Mutational analyses of residues homologous to Torpedo
nAChR QTrp-55 in a neuronal nAChR have demonstrated
e¡ects on both agonist and antagonist binding [18], while
substitutions at that position in GABAA receptor K1- and
Q2-subunits a¡ect agonist potency [19] and benzodiazepine
binding [20], respectively. In Torpedo nAChR substitution of
QTrp-55 by Leu reduces both ACh potency and the potency of
d-tubocurarine (dTC) as an inhibitor [21], but direct analysis
of dTC and ACh binding to this mutant establishes that dTC
binding is the same as wild-type and that the weakening of
dTC potency occurs because there is a major perturbation of
the binding of agonist and the mechanism of channel gating
[22]. The functional consequences of these substitutions estab-
lish that this position plays an important role in the confor-
mational transitions leading to channel gating, but they do
not distinguish between direct and indirect interactions with
bound ligands. The photoincorporation of [3H]nicotine into
QTrp-55 reported here is the ¢rst evidence of direct agonist
contact with an amino acid in a non-K-subunit.
Acknowledgements: This research was supported in part by USPHS
Grant NS 19522 and by an award in Structural Neurobiology by the
Keck Foundation. D.C.C. was supported in part by Training Grant
GM-07809 and R.E.M. was supported in part by a Lucille P. Markey
Charitable Trust Grant No. 84-17 (to Washington University School
of Medicine).
References
[1] Karlin, A. and Akabas, M.H. (1995) Neuron 15, 1231^1244.
[2] Hucho, F., Tsetlin, V.I. and Machold, J. (1996) Eur. J. Biochem.
239, 539^557.
[3] Tsigelny, I., Sugiyama, N., Sine, S.M. and Taylor, P. (1997)
Biophys. J. 73, 52^66.
[4] Sine, S.M. (1993) Proc. Natl. Acad. Sci. USA 90, 9436^9440.
[5] Sine, S.M., Kreienkamp, H.J., Bren, N., Maeda, R. and Taylor,
P. (1995) Neuron 15, 205^211.
[6] Prince, R.J. and Sine, S.M. (1996) J. Biol. Chem. 271, 25770^
25777.
[7] Martin, M., Czajkowski, C. and Karlin, A. (1996) J. Biol. Chem.
271, 13497^13503.
[8] Chiara, D.C. and Cohen, J.B. (1997) J. Biol. Chem. 272, 32940^
32950.
[9] Xie, Y., Chiara, D.C. and Cohen, J.B. (1994) Soc. Neurosci.
Abstr. 20, 1129.
[10] Czajkowski, C. and Karlin, A. (1995) J. Biol. Chem. 270, 3160^
3164.
[11] Middleton, R.E. and Cohen, J.B. (1991) Biochemistry 30, 6987^
6997.
[12] Schaºgger, H. and von Jagow, G. (1987) Anal. Biochem. 166, 368^
379.
[13] White, B.H. and Cohen, J.B. (1992) J. Biol. Chem. 267, 15770^
15783.
[14] Blanton, M.P. and Cohen, J.B. (1992) Biochemistry 31, 3738^
3750.
[15] Nomoto, H., Takahashi, N., Nagaki, Y., Endo, S., Arata, Y. and
Hayashi, K. (1986) Eur. J. Biochem. 157, 233^242.
[16] Tarentino, A.L., Gomez, C. and Plummer Jr., T.H. (1985) Bio-
chemistry 24, 4665^4671.
[17] Trimble, R.B. and Maley, F. (1984) Anal. Biochem. 141, 515^
522.
[18] Corringer, P.J., Galzi, J.L., Eisele, J.L., Bertrand, S., Changeux,
J.P. and Bertrand, D. (1995) J. Biol. Chem. 270, 11749^11752.
[19] Sigel, E., Baur, R., Kellenberger, S. and Malherbe, P. (1992)
EMBO J. 11, 2017^2023.
[20] Buhr, A., Baur, R. and Sigel, E. (1997) J. Biol. Chem. 272,
11799^11804.
[21] O’Leary, M.E., Filatov, G.N. and White, M.M. (1994) Am. J.
Phys. 266, C648^C653.
[22] Xie, Y. and Cohen, J.B. (1995) Biophys. J. 68, A406.
FEBS 19861 20-2-98
D.C. Chiara et al./FEBS Letters 423 (1998) 223^226226
